ASXL1 and acute myeloid leukemia: In conclusion, we report here that concurrence of CSF3RT618I, ASXL1, SETBP1, and SRSF2 mutations may co-contribute to AML transformation, but their interactions with PRKDC and MYOM2 mutations in the pathogenesis of CNL as well as their prognostic implications remain to be determined.